360 filings
Page 7 of 18
8-K
rpdgizcnzikoid
5 Aug 20
Miragen Reports Second Quarter 2020 Financial Results and Provides Business Updates
4:06pm
8-K
tj0ctbt77oileh9
24 Jul 20
Cobomarsen Receives Orphan Drug Designation from the U.S. Fda for the Treatment of T-cell Lymphoma
6:07am
8-K
2tnub1
2 Jul 20
Other Events
4:16pm
8-K
ppnjj lcnps2
23 Jun 20
Regulation FD Disclosure
9:17am
8-K
d18nci
19 Jun 20
Departure of Directors or Certain Officers
4:16pm
8-K
0t96 ocojdp
22 May 20
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
gw9igrirehiw
7 May 20
Miragen Reports First Quarter 2020 Financial Results and Provides Corporate Update
4:18pm
8-K
qcg xnhsspju9nhe
27 Apr 20
Entry into a Material Definitive Agreement
4:18pm
EFFECT
k90 1kodxh
15 Apr 20
Notice of effectiveness
12:15am
DEFA14A
xkero9f
10 Apr 20
Additional proxy soliciting materials
4:18pm
CORRESP
d5dx708dpw2p0rsceq
10 Apr 20
Correspondence with SEC
12:00am
UPLOAD
fbp8nps87yg9f6k
1 Apr 20
Letter from SEC
12:00am
S-8
tanccn
13 Mar 20
Registration of securities for employees
4:25pm
8-K
xxjp1c 3dttw34nf
11 Mar 20
Miragen Reports Fourth Quarter and Full Year 2019 Financial Results
4:06pm
8-K
4b80dg68
19 Feb 20
Departure of Directors or Certain Officers
4:15pm